Suppr超能文献

因费用问题而未使用药物的心血管疾病成年患者的住院和死亡情况:一项纵向分析。

Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis.

机构信息

Veterans Affairs Center for Clinical Practice Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI 48113-0170, USA.

出版信息

Med Care. 2010 Feb;48(2):87-94. doi: 10.1097/MLR.0b013e3181c12e53.

Abstract

CONTEXT

It is well-documented that the financial burden of out-of-pocket expenditures for prescription drugs often leads people with medication-sensitive chronic illnesses to restrict their use of these medications. Less is known about the extent to which such cost-related medication underuse is associated with increases in subsequent hospitalizations and deaths.

OBJECTIVE

We compared the risk of hospitalizations among 5401 and of death among 6135 middle-aged and elderly adults with one or more cardiovascular diseases (diabetes, coronary artery disease, heart failure, and history of stroke) according to whether participants did or did not report restricting prescription medications because of cost.

DESIGN AND SETTING

A retrospective biannual cohort study across 4 cross-sectional waves of the Health and Retirement Study, a nationally representative survey of adults older than age 50. Using multivariate logistic regression to adjust for baseline differences in sociodemographic and health characteristics, we assessed subsequent hospitalizations and deaths between 1998 and 2006 for respondents who reported that they had or had not taken less medicine than prescribed because of cost.

RESULTS

Respondents with cardiovascular disease who reported underusing medications due to cost were significantly more likely to be hospitalized in the next 2 years, even after adjusting for other patient characteristics (adjusted predicted probability of 47% compared with 38%, P < 0.001). The more survey waves respondents reported cost-related medication underuse during 1998 to 2004, the higher the probability of being hospitalized in 2006 (adjusted predicted probability of 54% among respondents reporting cost-related medication underuse in all 4 survey waves compared with 42% among respondents reporting no underuse, P < 0.001). There was no independent association of cost-related medication underuse with death.

CONCLUSIONS

In this nationally representative cohort, middle-aged and elderly adults with cardiovascular disease who reported cutting back on medication use because of cost were more likely to report being hospitalized over a subsequent 2-year period after they had reported medication underuse. The more extensively respondents reported cost-related underuse over time, the higher their adjusted predicted probability of subsequent hospitalization.

摘要

背景

有大量文献记录表明,人们因需自付药物费用而导致经济负担过重,往往会限制对处方药的使用,从而影响慢性病患者的治疗。但对于因费用问题而减少用药的行为与随后住院和死亡风险增加之间的关系,我们目前还知之甚少。

目的

我们比较了在参加健康与退休研究(一项针对 50 岁以上成年人的全国性调查)的 5401 名患有一种或多种心血管疾病(糖尿病、冠状动脉疾病、心力衰竭和中风病史)的中年和老年患者中,因费用问题限制处方药物使用的患者与未限制药物使用的患者的住院风险;并比较了在 6135 名患有一种或多种心血管疾病的中年和老年患者中,因费用问题限制处方药物使用的患者与未限制药物使用的患者的死亡风险。

设计与设置

这是一项回顾性的、每两年进行一次的队列研究,共涉及健康与退休研究的 4 个横断面波次。我们使用多变量逻辑回归来调整基线社会人口统计学和健康特征差异,评估了在 1998 年至 2006 年期间报告因费用问题而减少药物使用的患者在接下来的 2 年内的住院情况和死亡情况。

结果

患有心血管疾病且因费用问题而减少药物使用的患者在接下来的 2 年内更有可能住院,即使调整了其他患者特征后也是如此(调整后的预测概率为 47%,而未调整的预测概率为 38%,P < 0.001)。在 1998 年至 2004 年期间,报告因费用问题而减少药物使用的患者,其在 2006 年的住院概率越高(在报告在所有 4 次调查波次中均存在因费用问题而减少药物使用的患者中,调整后的预测概率为 54%,而在报告不存在药物使用减少的患者中,调整后的预测概率为 42%,P < 0.001)。因费用问题而减少药物使用与死亡之间没有独立的关联。

结论

在这项具有全国代表性的队列研究中,患有心血管疾病且因费用问题而减少药物使用的中年和老年患者在报告药物使用减少后的随后 2 年内更有可能报告住院。患者报告因费用问题而减少药物使用的次数越多,其调整后的预测住院概率就越高。

相似文献

2
The health effects of restricting prescription medication use because of cost.
Med Care. 2004 Jul;42(7):626-34. doi: 10.1097/01.mlr.0000129352.36733.cc.
4
Treat or eat: food insecurity, cost-related medication underuse, and unmet needs.
Am J Med. 2014 Apr;127(4):303-310.e3. doi: 10.1016/j.amjmed.2014.01.002. Epub 2014 Jan 17.
6
Cost-related medication underuse: prevalence among hospitalized managed care patients.
J Hosp Med. 2012 Feb;7(2):104-9. doi: 10.1002/jhm.948. Epub 2011 Oct 3.
10
Cost-related underuse of medications in older adults: ELSI-Brazil.
Rev Saude Publica. 2018 Oct 25;52Suppl 2(Suppl 2):8s. doi: 10.11606/S1518-8787.2018052000622.

引用本文的文献

1
Associations of serial negative income shock and all-cause mortality: a longitudinal study in China.
BMJ Public Health. 2024 Oct 22;2(2):e001512. doi: 10.1136/bmjph-2024-001512. eCollection 2024 Dec.
2
Clinical Decision Support and Cardiometabolic Medication Adherence: A Randomized Clinical Trial.
JAMA Netw Open. 2025 Jan 2;8(1):e2453745. doi: 10.1001/jamanetworkopen.2024.53745.
3
Clinically meaningful classes of financial toxicity for patients with diabetes.
J Patient Rep Outcomes. 2025 Jan 6;9(1):2. doi: 10.1186/s41687-024-00834-5.
4
5
A Randomized Controlled Trial to Improve Unmet Social Needs and Clinical Outcomes Among Adults with Diabetes.
J Gen Intern Med. 2024 Oct;39(13):2415-2424. doi: 10.1007/s11606-024-08708-8. Epub 2024 Mar 11.
6
Protocol of a patient randomized clinical trial to improve medication adherence in primary care.
Contemp Clin Trials. 2024 Jan;136:107385. doi: 10.1016/j.cct.2023.107385. Epub 2023 Nov 11.
7
Food Insecurity and Perceived Financial Stress are Associated with Cost-related Medication Non-adherence in Stroke.
J Health Care Poor Underserved. 2023;34(2):625-639. doi: 10.1353/hpu.2023.0054.
9
Association of patient-reported financial barriers with healthcare utilization among Medicare beneficiaries with a history of cancer.
J Cancer Surviv. 2024 Oct;18(5):1697-1708. doi: 10.1007/s11764-023-01409-x. Epub 2023 Jun 2.
10
Patients want to talk about their out-of-pocket costs-Can real-time benefit tools help?
J Am Geriatr Soc. 2023 May;71(5):1365-1368. doi: 10.1111/jgs.18342. Epub 2023 Mar 20.

本文引用的文献

1
Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries.
Circulation. 2008 Mar 11;117(10):1261-8. doi: 10.1161/CIRCULATIONAHA.107.735605. Epub 2008 Feb 19.
2
Impact of decreasing copayments on medication adherence within a disease management environment.
Health Aff (Millwood). 2008 Jan-Feb;27(1):103-12. doi: 10.1377/hlthaff.27.1.103.
3
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.
Ann Intern Med. 2008 Feb 5;148(3):169-77. doi: 10.7326/0003-4819-148-3-200802050-00200. Epub 2008 Jan 7.
4
The impact of Medicare Part D on prescription drug use by the elderly.
Health Aff (Millwood). 2007 Nov-Dec;26(6):1735-44. doi: 10.1377/hlthaff.26.6.1735.
7
Linking cost sharing to value: an unrivaled yet unrealized public health opportunity.
Ann Intern Med. 2007 Apr 17;146(8):602-5. doi: 10.7326/0003-4819-146-8-200704170-00011.
8
Value-based insurance design.
Health Aff (Millwood). 2007 Mar-Apr;26(2):w195-203. doi: 10.1377/hlthaff.26.2.w195. Epub 2007 Jan 30.
9
Grounding coverage in value: a paradigm for linking quality and costs.
Med Care. 2006 May;44(5):389-91. doi: 10.1097/01.mlr.0000216191.86056.a1.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验